Evidence map›Paper›PMID 36768366›Full record

ArticleInternational journal of molecular sciences2023

Comparison of Rheological Properties of Healthy versus Dupuytren Fibroblasts When Treated with a Cell Contraction Inhibitor by Atomic Force Microscope.

Sandra Pérez-Domínguez, Javier López-Alonso, Frank Lafont, Manfred Radmacher

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Sandra Pérez-DomínguezInstitute of Biophysics, University of Bremen, 28359 Bremen, Germany.
Javier López-AlonsoUniversity of Lille, CNRS, INSERM, CHU Lille, Institute Pasteur Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59021 Lille, France.
Frank LafontUniversity of Lille, CNRS, INSERM, CHU Lille, Institute Pasteur Lille, U1019-UMR 9017-CIIL-Center for Infection and Immunity of Lille, 59021 Lille, France.
Manfred RadmacherInstitute of Biophysics, University of Bremen, 28359 Bremen, Germany.ORCID 0000-0001-8744-4541
Centre National de la Recherche Scientifique · FRUniversity of Bremen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mechanical properties of healthy and Dupuytren fibroblasts were investigated by atomic force microscopy (AFM). In addition to standard force curves, rheological properties were assessed using an oscillatory testing methodology, in which the frequency was swept from 1 Hz to 1 kHz, and data were analyzed using the structural damping model. Dupuytren fibroblasts showed larger apparent Young's modulus values than healthy ones, which is in agreement with previous results. Moreover, cell mechanics were compared before and after ML-7 treatment, which is a myosin light chain kinase inhibitor (MLCK) that reduces myosin activity and hence cell contraction. We employed two different concentrations of ML-7 inhibitor and could observe distinct cell reactions. At 1 µM, healthy and scar fibroblasts did not show measurable changes in stiffness, but Dupuytren fibroblasts displayed a softening and recovery after some time. When increasing ML-7 concentration (3 µM), the majority of cells reacted, Dupuytren fibroblasts were the most susceptible, not being able to recover from the drug and dying. These results suggested that ML-7 is a potent inhibitor for MLCK and that myosin II is essential for cytoskeleton stabilization and cell survival.

Indexed as

CytoskeletonDupuytren ContractureFibroblastsMicroscopy, Atomic ForceMuscle ContractionMyosin Light ChainsAzepinesHumansMechanical PhenomenaMyosin-Light-Chain KinaseNaphthalenesAzepinesML 7Myosin-Light-Chain KinaseMyosin Light ChainsNaphthalenesatomic force microscopyDupuytren’s diseasefibroblastinhibitionML-7rheology

Identifiers

PMID36768366
PMCPMC9917339
OpenAlexW4317521222

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.